Lori Freedman serves as the Chief Administrative and Legal Officer at Organogenesis Holdings Inc Class A, a leading regenerative medicine company. In her role, Freedman is responsible for overseeing the company's legal affairs, compliance, and administrative functions. She plays a crucial role in guiding the company's strategic direction and ensuring that Organogenesis operates within the bounds of legal and regulatory requirements. Freedman brings a wealth of experience to her position, having spent over two decades in the legal and healthcare industries. Prior to joining Organogenesis, she held senior legal positions at several prominent companies, where she honed her skills in corporate governance, intellectual property, and regulatory compliance. Her background in healthcare law has been particularly valuable in navigating the complex landscape of regenerative medicine and ensuring that Organogenesis remains at the forefront of innovation while maintaining the highest standards of patient safety and product quality. Under Freedman's leadership, Organogenesis has successfully navigated numerous legal and regulatory challenges, enabling the company to expand its product portfolio and reach new markets. Her strategic vision and commitment to excellence have been instrumental in driving the company's growth and solidifying its position as a leader in the field of regenerative medicine. Freedman's contributions have been widely recognized within the industry, and she continues to be a driving force behind Organogenesis' mission to improve patient outcomes through cutting-edge medical solutions.